The Visitor Health System Board approved the university's approval of the contract with Cardinal Health and Health Carousel through the University Medical Center. This approval is required for contracts exceeding $5 million annually. The new agreement will provide the university's health system with T-cell therapy and international staffing services. In addition, the Board approved the appointments, privileges, and resignations of clinical staff at the University Medical Center.
The Health System Committee is responsible for: manage University medical operations. The university asked the Board of Regents for approval of a proposed contract with pharmaceutical company Cardinal Health LLC. provide CAR T cell therapy — A therapy used to treat cancer. Another company with contracts totaling more than $5 million per year is Health Carousel LLC. specialize We help hospitals secure staffing.
The costs associated with these agreements are detailed in the Board's operating budget and are also subject to approval by the Finance Committee.
Douglas E. Lischke, University Health's chief financial officer, led the board in reviewing the financial information provided by the university. The board's agenda states that the university's medical benefits were satisfactory despite facing industry challenges related to labor and inflation.
In consideration of its oversight of academic medical centers, the board advanced credentialing operations, including approval of credentials and privileges for academic hospital clinical staff. The Clinical Staff Executive Committee, a subcommittee of the university hospital responsible for managing clinical staff, Offers Provides recommendations regarding appointments and qualifications to the Board of Directors.
board granted Various statuses of hospital personnel, including designations such as attending physician and nurse.
University Medical Center CEO Wendy Horton updated the board. Houghton, who took over in November 2020, discussed the center's turnover, operational enhancements, and advances in quality and safety measures. The board's agenda notes that the center's voluntary turnover of nurses has returned to pre-pandemic levels, meaning nurse retention has increased.
Representatives from the university's School of Medicine and School of Nursing provided further updates. School of Medicine Dean Melina R. Kibe provided an update on research projects, including the renewal of a five-year research grant of more than $3.7 million from the National Institutes of Health.The grant is Award The donation will be made to infectious disease expert Dr. Scott Hasel to fund tuberculosis research.
Marianne Bernholt, dean of the School of Nursing, spoke about the school's donation to the university's Celebrate the Future campaign (fundraiser). I support Major investments in universities. As of January 30, 2024, the School of Nursing has contributed her $88,727,327 to this campaign. This exceeded the target amount by 118%.
The Health System Committee will reconvene during the June Board of Visitors meeting.
